Source:http://linkedlifedata.com/resource/pubmed/id/12031639
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2002-5-28
|
pubmed:abstractText |
Even moderate increases in levels of homocysteine cause cardiovascular degeneration. Various genetic and nutritional factors affect plasma homocysteine concentrations, and hyperhomocysteinemia damages vascular endothelial cells; hence their functions are disrupted. In diabetes mellitus, homocysteine metabolism is altered and as a result, more severe diabetic complications are expected when hyperhomocysteinemia occurs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0188-4409
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
305-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12031639-Animals,
pubmed-meshheading:12031639-Diabetes Mellitus, Experimental,
pubmed-meshheading:12031639-Dose-Response Relationship, Drug,
pubmed-meshheading:12031639-Homocysteine,
pubmed-meshheading:12031639-Insulin,
pubmed-meshheading:12031639-Rats,
pubmed-meshheading:12031639-Streptozocin
|
pubmed:articleTitle |
Insulin increases homocysteine levels in a dose-dependent manner in diabetic rats.
|
pubmed:affiliation |
Department of Biochemistry, College of Medicine, Firat University, Elazig, Turkey.
|
pubmed:publicationType |
Journal Article
|